(Q41889550)

English

Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321

scientific article published on 6 March 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321 (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

phase II clinical trial

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

I-Chow Hsu

1

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Kyounghwa Bae

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Katsuto Shinohara

3

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Jean Pouliot

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

James Purdy

5

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Geoffrey Ibbott

6

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Joycelyn Speight

7

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Eric Vigneault

8

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Robert Ivker

9

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Howard Sandler

10

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

language of work or name

0 references

publication date

6 March 2010

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

78

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

3

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

751-758

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946454

5 June 2018

Is alpha/beta for prostate tumors really low?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946454

5 June 2018

Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946454

5 June 2018

Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946454

5 June 2018

Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946454

18 August 2018

High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946454

18 August 2018

Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946454

18 August 2018

High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946454

18 August 2018

Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Needle displacement during HDR brachytherapy in the treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20207506

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2009.08.048

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41889550&oldid=1550415868"